PD-1/PD-L1 Inhibitors in Cervical Cancer

Cervical cancer is one of the most common gynecological tumors, and the majority of early-stage cervical cancer patients achieve good recovery through surgical treatment and concurrent chemoradiotherapy (CCRT). However, for patients with recurrent, persistent, metastatic cervical cancer, effective t...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yuncong, Wu, Li, Tong, Ruizhan, Yang, Feiyue, Yin, Limei, Li, Mengqian, You, Liting, Xue, Jianxin, Lu, You
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367228/
https://www.ncbi.nlm.nih.gov/pubmed/30774597
http://dx.doi.org/10.3389/fphar.2019.00065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6367228/
https://www.ncbi.nlm.nih.gov/pubmed/30774597
http://dx.doi.org/10.3389/fphar.2019.00065

Ejemplares similares